Dwivedi Sudhanshu Kumar, Sharma Akhil Kumar, Agrawal Anant, Doomra Kapil, Chaudhary Gaurav Kumar, Chandra Sharad, Bhandari Monika, Vishwakarma Pravesh, Pradhan Akshyaya, Sethi Rishi, Shukla Ayush, Singh Abhishek, Safal Safal
Department of Cardiology, King George's Medical University, Lucknow, India.
Front Cardiovasc Med. 2024 Oct 9;11:1455018. doi: 10.3389/fcvm.2024.1455018. eCollection 2024.
Non-ischemic symptomatic reversible bradyarrhythmia is a poorly characterized yet common clinical challenge. This study aimed to assess the incidence and predictors of recurrence and the need for permanent cardiac pacing in patients with non-ischemic symptomatic reversible bradyarrhythmia.
This prospective single-center study enrolled 124 consecutive adult patients with non-ischemic symptomatic reversible bradyarrhythmia who were followed up for up to 24 months after conservative management during index hospitalization. The primary endpoint was a recurrence of bradyarrhythmia requiring permanent cardiac pacing. The secondary endpoint was a composite of recurrence requiring permanent pacing, readmission, or death. Univariate and multivariate analyses were conducted to determine the predictors of the endpoints.
Sinus node and atrioventricular node diseases were seen in 66.1% and 33.9% of patients, respectively. The most common causes of bradyarrhythmia were negative chronotropic drugs (58.1%) and hyperkalemia (55.6%). Permanent pacing was required in 21.8% of patients after a recurrence. Advanced atrioventricular block at presentation (HR: 6.10, 95% CI: 2.45-15.20, < 0.001) and bifascicular block at discharge (HR: 3.63, 95% CI: 1.58-8.33, = 0.002) during index hospitalization were significant independent predictors of recurrence requiring cardiac pacing.
Non-ischemic symptomatic reversible bradyarrhythmia is associated with a high risk of recurrence. Permanent cardiac pacing should be considered during index hospitalization in patients with advanced atrioventricular block and/or bifascicular block.
非缺血性症状性可逆性缓慢性心律失常是一种特征描述不足但常见的临床挑战。本研究旨在评估非缺血性症状性可逆性缓慢性心律失常患者的复发率、复发的预测因素以及永久心脏起搏的必要性。
这项前瞻性单中心研究纳入了124例连续性成年非缺血性症状性可逆性缓慢性心律失常患者,在首次住院期间接受保守治疗后进行了长达24个月的随访。主要终点是需要永久心脏起搏的缓慢性心律失常复发。次要终点是需要永久起搏、再次入院或死亡的复合终点。进行单因素和多因素分析以确定终点的预测因素。
分别有66.1%和33.9%的患者出现窦房结和房室结疾病。缓慢性心律失常最常见的原因是负性变时药物(58.1%)和高钾血症(55.6%)。复发后21.8%的患者需要永久起搏。首次住院期间出现的高级房室传导阻滞(HR:6.10,95%CI:2.45 - 15.20,P<0.001)和出院时的双分支阻滞(HR:3.63,95%CI:1.58 - 8.33,P = 0.002)是需要心脏起搏复发的显著独立预测因素。
非缺血性症状性可逆性缓慢性心律失常复发风险高。对于有高级房室传导阻滞和/或双分支阻滞的患者,在首次住院期间应考虑永久心脏起搏。